Blog
Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade
Silence Therapeutics PLC Sponsored ADR (SLN) closed the last trading session at $5.14, gaining 68.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term
Wall Street Analysts Believe Ouster (OUST) Could Rally 38.91%: Here's is How to Trade
Shares of Ouster, Inc. (OUST) have gained 48.6% over the past four weeks to close the last trading session at $10.28, but there could still be a solid upside left in the stock if short-term price
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?
Shares of Septerna, Inc. (SEPN) have gained 57.8% over the past four weeks to close the last trading session at $9.42, but there could still be a solid upside left in the stock if short-term price
How Much Upside is Left in SharkNinja, Inc. (SN)? Wall Street Analysts Think 25.32%
SharkNinja, Inc. (SN) closed the last trading session at $100.59, gaining 35.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Think North American Construction (NOA) Could Surge 51.09%: Read This Before Placing a Bet
North American Construction (NOA) closed the last trading session at $17.01, gaining 11.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet
Apogee Therapeutics Inc. (APGE) closed the last trading session at $40.34, gaining 13.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Oatly Group (OTLY) Could Surge 82.65%: Read This Before Placing a Bet
Oatly Group AB Sponsored ADR (OTLY) closed the last trading session at $10.26, gaining 18.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High?
Olema Pharmaceuticals, Inc. (OLMA) closed the last trading session at $5.08, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Think Shift4 Payments (FOUR) Could Surge 27.22%: Read This Before Placing a Bet
Shares of Shift4 Payments (FOUR) have gained 17.2% over the past four weeks to close the last trading session at $90.26, but there could still be a solid upside left in the stock if short-term price
Karooooo Ltd. (KARO) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Karooooo Ltd. (KARO) is looking like an interesting pick, as it just reached a key level of support. KARO's 50-day simple moving average crossed above its 200-day
MainStreet Bank (MNSB) Just Flashed Golden Cross Signal: Do You Buy?
MainStreet Bank (MNSB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MNSB's 50-day simple moving average broke out above its
Reasons to Include Leonardo DRS Stock in Your Portfolio Right Now
Leonardo DRS, Inc. DRS, with a robust backlog, rising earnings estimates, efficient debt management and strong liquidity, offers a great investment opportunity in the Zacks Aerospace Defense
Here's Why Unisys (UIS) Looks Ripe for Bottom Fishing
Shares of Unisys (UIS) have been struggling lately and have lost 8.7% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock
Why Planet Fitness (PLNT) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Carnival (CCL) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Crown Holdings (CCK) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Why Telefonica (TEF) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Why SkyWest (SKYW) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
ARMP Soars 72% in a Month Following Infectious Disease Study Success
Armata Pharmaceuticals ARMP shares have skyrocketed 72.3% in the past month. The massive surge in the stock price was observed after the company announced positive top-line results from its early to